31P Magnetic Resonance Spectroscopic Imaging of brain tumours

Not yet recruiting

• Conditions: brain tumour; hersen tumoren; glial tumour

• Registration Number: NL-OMON32708
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

patients with a glial tumour and without MRI contra-indication

Exclusion Criteria

patients with MRI contra-indication. patients that are claustrofobic. Patients with pacemakers or neurostimulators. Patients with large metal implants

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p> In this study we try to characterise the phosphoester content in brain<br /><br>tumours. The main study parameters are the peak areas of the (glycerol)choline<br /><br>and (glycerol)ethanolamine in the 31P MR spectrum. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1H MRS spectra.</p><br>